Bedside Lateral Flow Assay for Rapid Sputum Gram Classification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current sputum sample collection and transportation methods are prone to leakage, leading to contamination and delayed microbial testing results, resulting in unnecessary antibiotic use and antibiotic resistance, which increases healthcare costs and patient toxicity.
Innovation Solution
A lateral flow assay device that rapidly classifies bacteria as Gram negative or Gram positive within 30 minutes, using membrane-based immunoassay technology with specific antibodies and colloidal gold nanoparticles, integrated into a bedside device for immediate antibiotic prescription guidance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional sputum sample collection and transportation methods are used, then samples can be collected and transported to the lab, but leakage and spillage occur causing contamination and delayed results
Solution Approach 1:
The patent combines the sample collection container, transportation system, and testing device into an integrated bedside testing system. The sputum collection container is directly connected to the lateral flow assay device, eliminating separate transportation steps and preventing leakage during transit while enabling immediate testing at the patient's bedside.
Solution Approach 2:
The patent introduces a sealed connection system with flexible tubing that acts as an intermediary between the collection container and testing device. This intermediary component prevents leakage and contamination during sample transfer, maintaining sample integrity throughout the process.
2Measurement precision
If Gram stain testing is performed using traditional laboratory methods, then bacterial classification can be obtained, but results are delayed 12-24 hours due to transportation and lab backlog
Solution Approach 1:
The patent enables the testing device to perform Gram stain classification independently at the bedside without requiring sample transportation to a centralized laboratory. The integrated system includes all necessary reagents and testing components, allowing immediate processing and eliminating lab backlog delays while maintaining diagnostic accuracy.
Solution Approach 2:
The patent performs the Gram stain classification test immediately upon sample collection at the bedside, before the patient leaves the clinical area. This preliminary action eliminates the need for subsequent transportation and waiting for lab results, providing rapid diagnostic information for immediate clinical decision-making.
3Reliability
If broad spectrum antibiotics are administered while waiting for microbial data, then all possible organisms are covered, but toxic side effects and antibiotic resistance increase
Solution Approach 1:
The patent provides immediate Gram stain classification results that give real-time feedback to clinicians about the type of bacteria present (Gram-positive or Gram-negative). This feedback enables clinicians to narrow antibiotic therapy appropriately based on actual pathogen identification, avoiding unnecessary broad-spectrum antibiotic use and reducing the development of antibiotic resistance while maintaining effective treatment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Reduces the time for microbial results, decreases unnecessary antibiotic use, and helps in early identification of infections, thereby improving patient outcomes and reducing antibiotic resistance and treatment costs.
Implementation Method 1
The device utilizes membrane-based lateral flow immunoassay technology to perform the Gram classification test
Implementation Method 2
The sample then is exposed to the test strip
Data Source
AI summary
There is provided a lateral flow assay that can provide an indication of Gram negative (GN) or Gram positive (GP) infection (or both) within 30 minutes, and desirably in less than 15 minutes. The immediate result would signal the presence of Gram negative bacteria, Gram positive bacteria, both Gram negative and Gram positive bacteria, or no bacteria detected. The detection level would be above a specific bacterial concentration threshold that is clinically significant infection source (e.g. 10^3 cfu/ml) versus the presence of a colonizing bacteria that is not a part of the active infection.